|
Jacques Orgiazzi is professor of Internal Medicine in Lyon and head of
a Clinical Service at the University Hospital Centre Hospitalier Lyon-Sud.
He has been interested for long in thyroid autoimmunity. He devised a new
detection assay for anti-TSH receptor antibodies of Graves' disease and
introduced the concept of blocking anti-TSH receptor antibodies. He studied
biological as well as clinical implications of the various types of these
antibodies. He also worked on anti-thyroid specific immune cytotoxicity.
More recently, with Professor C. Thivolet, his research group in INSERM
Unit 449, extended its scope to islet immunopathology of insulin-dependent
diabetes mellitus at both the clinical and experimental levels. Professor
Orgiazzi is well-known in the field of endocrinology. He served as member
of the Executive Committee of the European Thyroid Association.
Correspondence Address: Prof. Jacques Orgiazzi, M.D. Centre Hospitalier Lyon Sud 69495 PIERRE BENITE Unité INSERM U 449 Faculté Laennec rue Guillaume Paradin 69372 LYON Cedex 08 |
